Care Bare Rx review
A LegitScript-certified, HIPAA-compliant multi-service platform bundling weight loss with hair, TRT, sexual health and NAD+ — both oral (Rybelsus, oral tirzepatide) and injectable compounded routes, real brand Ozempic from ~$705/mo, and coverage across all 50 states plus Puerto Rico, but the 3-month plan is a real trap: it costs more per month than either month-to-month or the 6-month plan.
- Semaglutide
- $199/mo month-to-month ($185/mo only on a 12-month prepay; the 3-month tier is dearer at $249/mo)
- Tirzepatide
- $299/mo month-to-month ($293/mo only on a 12-month prepay; the 3-month tier is dearer at $356/mo)
- Coverage
- All 50 states + Puerto Rico
- Brand-name
- Yes
Semaglutide · modeled / year
$2,388
Tirzepatide · modeled / year
$3,588
Pricing verified August 2026
The Index scorecard
Care Bare Rx scored on our six Cost-Efficiency Index factors. See the methodology.
Where the value is
- LegitScript-certified and HIPAA-compliant, with both oral (Rybelsus, oral tirzepatide) and injectable options
- Real brand-name Ozempic available (from ~$705/mo) for anyone who specifically wants the on-label pen
- Coverage across all 50 states plus Puerto Rico — wider than most compounded telehealth options
- One platform for weight loss plus hair, TRT, sexual health and NAD+ if you want to consolidate care
The tradeoffs
- The 3-month plan is a real pricing trap — it costs more per month ($249 semaglutide / $356 tirzepatide) than either month-to-month or the 6-month plan
- The cheapest per-month rate requires a 12-month prepay commitment ($2,218 semaglutide / $3,518 tirzepatide total)
- No named clinicians, founding year or parent company disclosed, so transparency is thin
- Compounded medications are not FDA-approved finished drugs
The bottom line
Best for: People consolidating several telehealth needs on one verified platform who are willing to commit to a 12-month plan to get the cheapest per-month rate. A LegitScript-certified, HIPAA-compliant multi-service platform bundling weight loss with hair, TRT, sexual health and NAD+ — both oral (Rybelsus, oral tirzepatide) and injectable compounded routes, real brand Ozempic from ~$705/mo, and coverage across all 50 states plus Puerto Rico, but the 3-month plan is a real trap: it costs more per month than either month-to-month or the 6-month plan.
Ranked #25 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.
Compare with other providers
All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Care Bare Rx.
- #29Curex— A discounted first month ($49-$149) steps up to a 'starting at $199' ongoing rate — real, but not the flat, fully-disclosed price the headline implies, and California loses the injectable route entirely.81/100
- #30Henry Meds— A transparent flat-fee pioneer — the pricing is clean and modelable, but it now sits at the higher end, so the value per dollar has slipped.81/100
- #31Luma Health Co— Luma Health Co is a small telehealth weight-loss practice whose own pricing is gated behind a booking widget rather than published on a static page.81/100
- #32Trimi Health— Publishes a complete four-rung price ladder for both molecules and advertises the deepest rung: the $99 semaglutide and $125 tirzepatide headlines are annual-prepay rates, while month-to-month is $175 and $235.78/100
- #33REMEVi— REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.80/100
- #34Vaylen— Vaylen is a pure GLP-1 specialist offering compounded semaglutide ($179/mo), compounded tirzepatide ($239/mo), compounded oral GLP-1 ($259/mo), and brand-name Ozempic, Zepbound, and Wegovy.80/100
The 18 programs nearest this one
Pricing, states and verification reflect Care Bare Rx's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Care Bare Rx's site. Not medical advice; see our disclosure.